🟢 Moleculin Biotech is trading 6.67% up in pre-market — no explicit explanation identified

Moleculin Biotech is trading 6.67% up in pre-market at $0.63; no explicit explanation for the move was identified.

• No new company-specific announcement dated August 21, 2026, was identified.
• The latest company update, dated August 14, reported encouraging MIRACLE trial remission data and continued enrollment.
• That update appears stale for this alert.